Skip to main navigation PATIENT PHARMA DIAGNOSTICS COVID-19 SCIENCE CLINICAL STUDIES COMPANY INVESTORS SEC Filings Home Investors SEC Filings SEC Filings GROUP FILING YEAR - Any - Filing date Description Form View Nov 24, 2021 Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act 6-K 0001558370-21-016310.pdf 0001558370-21-016310.rtf 0001558370-21-016310.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML Nov 18, 2021 Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act 6-K 0000950103-21-018025.pdf 0000950103-21-018025.rtf 0000950103-21-018025.xls View HTML Nov 04, 2021 Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act 6-K 0000950103-21-017348.pdf 0000950103-21-017348.rtf 0000950103-21-017348.xls View HTML Oct 28, 2021 Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act 6-K 0000950103-21-016728.pdf 0000950103-21-016728.rtf 0000950103-21-016728.xls View HTML Oct 06, 2021 Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act 6-K 0000950103-21-015526.pdf 0000950103-21-015526.rtf 0000950103-21-015526.xls View HTML Sep 07, 2021 Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act 6-K 0001558370-21-012233.pdf 0001558370-21-012233.rtf 0001558370-21-012233.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML Sep 01, 2021 Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act 6-K 0000950103-21-013343.pdf 0000950103-21-013343.rtf 0000950103-21-013343.xls View HTML Jul 27, 2021 Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act 6-K 0000950103-21-011192.pdf 0000950103-21-011192.rtf 0000950103-21-011192.xls View HTML Jul 12, 2021 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing 144 0000950103-21-010322.pdf 0000950103-21-010322.rtf 0000950103-21-010322.xls View HTML Jul 07, 2021 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing 144 0000950103-21-010150.pdf 0000950103-21-010150.rtf 0000950103-21-010150.xls View HTML Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Next page Next › Last page Last » Data provided by Kaleidoscope. Toolkit Print Page Email Alerts Contact IR Pharma Diagnostics Company Newsletter SUBSCRIBE NOW Follow Us © 2021 CENTOGENE N.V. Imprint Data Protection HIPAA Privacy Terms of Use Terms and Conditions Whistleblower Hotline